| Heading: |
CSL Vifor |
| Question ID: |
1752378 |
| UIN: |
21836 |
| House: |
Commons |
| Date tabled: |
2025-01-03 |
| Asking Member ID: |
5209 |
| Asking Member display name: |
Peter Fortune
|
| Asking Member handle: |
petertfortune
|
| Asking Member Twitter reference: |
@petertfortune
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Business and Trade, if he will make an assessment of the adequacy of the accessibility of the consultation entitled Investigation into suspected anti-competitive conduct by Vifor Pharma in relation to intravenous iron tre |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-01-10 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4418 |
| Answering Member display name: |
Justin Madders
|
| Answering Member handle: |
justinmadders
|
| Answering Member Twitter reference: |
@justinmadders
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Competition and Markets Authority (CMA) is the UK's independent competition authority, and its consultations, including the live consultation relating to commitments offered by Vifor Pharma (https://www.gov.uk/government/consultations/consultation-on-... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
214 |
| Answering body name: |
Department for Business and Trade |
| Tweeted: |
true |